AIM
CRMD icon

Aigen Investment Management’s CorMedix CRMD Stock Holding History

Aigen Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,079
Closed -$117K – 661
2025
Q3 		$117K Buy
+10,079
New +$122K 0.02% 729
2025
Q1 		– Sell
-11,545
Closed -$93.5K – 802
2024
Q4 		$93.5K Buy
+11,545
New +$115K 0.02% 670

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Aigen Investment Management's CRMD Position: Q4 2025 in Review

Aigen Investment Management sold out of CorMedix (CRMD) in Q4 2025, closing a stake of 10,079 shares — an estimated $117K sold.

Aigen Investment Management first reported a position in CRMD in Q4 2024 and held it in 2 quarters. The position peaked at $117K in Q3 2025. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

  • Aigen Investment Management reported no remaining CorMedix position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 10,079 CorMedix shares in Q4 2025, an estimated $117K.
  • Aigen Investment Management first reported a position in CorMedix in Q4 2024 and held it in 2 quarters.
  • Aigen Investment Management's CorMedix position peaked at $117K in Q3 2025.
  • 198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.